Comparative effectiveness research for prostate cancer radiation therapy

Current status and future directions

Xinglei Shen, Nicholas Zaorsky, Mark V. Mishra, Kathleen A. Foley, Terry Hyslop, Sarah Hegarty, Laura T. Pizzi, Adam P. Dicker, Timothy N. Showalter

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

Original languageEnglish (US)
Pages (from-to)37-54
Number of pages18
JournalFuture Oncology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Comparative Effectiveness Research
Prostatic Neoplasms
Radiotherapy
Inventions
Therapeutics
Androgens
Direction compound
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Shen, Xinglei ; Zaorsky, Nicholas ; Mishra, Mark V. ; Foley, Kathleen A. ; Hyslop, Terry ; Hegarty, Sarah ; Pizzi, Laura T. ; Dicker, Adam P. ; Showalter, Timothy N. / Comparative effectiveness research for prostate cancer radiation therapy : Current status and future directions. In: Future Oncology. 2012 ; Vol. 8, No. 1. pp. 37-54.
@article{4d87abe6ef344f9c8a7e5337549c0324,
title = "Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions",
abstract = "Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.",
author = "Xinglei Shen and Nicholas Zaorsky and Mishra, {Mark V.} and Foley, {Kathleen A.} and Terry Hyslop and Sarah Hegarty and Pizzi, {Laura T.} and Dicker, {Adam P.} and Showalter, {Timothy N.}",
year = "2012",
month = "1",
day = "1",
doi = "10.2217/fon.11.131",
language = "English (US)",
volume = "8",
pages = "37--54",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "1",

}

Shen, X, Zaorsky, N, Mishra, MV, Foley, KA, Hyslop, T, Hegarty, S, Pizzi, LT, Dicker, AP & Showalter, TN 2012, 'Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions', Future Oncology, vol. 8, no. 1, pp. 37-54. https://doi.org/10.2217/fon.11.131

Comparative effectiveness research for prostate cancer radiation therapy : Current status and future directions. / Shen, Xinglei; Zaorsky, Nicholas; Mishra, Mark V.; Foley, Kathleen A.; Hyslop, Terry; Hegarty, Sarah; Pizzi, Laura T.; Dicker, Adam P.; Showalter, Timothy N.

In: Future Oncology, Vol. 8, No. 1, 01.01.2012, p. 37-54.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Comparative effectiveness research for prostate cancer radiation therapy

T2 - Current status and future directions

AU - Shen, Xinglei

AU - Zaorsky, Nicholas

AU - Mishra, Mark V.

AU - Foley, Kathleen A.

AU - Hyslop, Terry

AU - Hegarty, Sarah

AU - Pizzi, Laura T.

AU - Dicker, Adam P.

AU - Showalter, Timothy N.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

AB - Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=83655182378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655182378&partnerID=8YFLogxK

U2 - 10.2217/fon.11.131

DO - 10.2217/fon.11.131

M3 - Review article

VL - 8

SP - 37

EP - 54

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 1

ER -